Develops drugs for age-related brain disorders.
Jun 2026Revenue $331K/yrExpenses $31.5M/yr
No trendCash runway ≈ 11 months from Jun 2026
Figures by year
When will CervoMed be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $331K and expenses $31.5M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $4.01M | $32.3M | −$28.3M |
| Dec 2024 | $9.74M | $28.0M | −$18.2M |
| Dec 2023 | $7.14M | $15.0M | −$7.81M |
| Dec 2022 | $0.00 | $3.48M | −$3.48M |
| Dec 2013 | $71.7K | $12.9M | −$12.8M |
| Dec 2012 | $375K | $12.2M | −$11.8M |
| Dec 2011 | $570K | $17.0M | −$16.4M |
| Dec 2010 | $40.2K | $7.68M | −$7.64M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.